Inter-epitope spacer variation within polytopic L2-based human papillomavirus antigens affects immunogenicity

Yueru Zhang,Filipe Colaco Mariz,Peter Sehr,Gloria Spagnoli,Karl Moritz Koenig,Simay Çelikyürekli,Tim Kreuziger,Xueer Zhao,Angelo Bolchi,Simone Ottonello,Martin Müller
DOI: https://doi.org/10.1038/s41541-024-00832-0
2024-02-24
npj Vaccines
Abstract:The human papillomavirus minor capsid protein L2 is being extensively explored in pre-clinical studies as an attractive vaccine antigen capable of inducing broad-spectrum prophylactic antibody responses. Recently, we have developed two HPV vaccine antigens – PANHPVAX and CUT-PANHPVAX- both based on heptameric nanoparticle antigens displaying polytopes of the L2 major cross-neutralizing epitopes of eight mucosal and twelve cutaneous HPV types, respectively. Prompted by the variable neutralizing antibody responses against some of the HPV types targeted by the antigens observed in previous studies, here we investigated the influence on immunogenicity of six distinct glycine-proline spacers inserted upstream to a specific L2 epitope. We show that spacer variants differentially influence antigen immunogenicity in a mouse model, with the antigen constructs M8merV6 and C12merV6 displaying a superior ability in the induction of neutralizing antibodies as determined by pseudovirus-based neutralization assays (PBNAs). L2-peptide enzyme-linked immunosorbent assay (ELISA) assessments determined the total anti-L2 antibody level for each antigen variant, showing for the majority of sera a correlation with their repective neutralizing antibody level. Surface Plasmon Resonance revealed that L2 epitope-specific, neutralizing monoclonal antibodies (mAbs) display distinct avidities to different antigen spacer variants. Furthermore, mAb affinity toward individual spacer variants was well correlated with their neutralizing antibody induction capacity, indicating that the mAb affinity assay predicts L2-based antigen immunogenicity. These observations provide insights on the development and optimization of L2-based HPV vaccines.
immunology,medicine, research & experimental
What problem does this paper attempt to address?
The paper primarily explores the design and optimization of L2 protein-based antigens in human papillomavirus (HPV) vaccines. Specifically, the study focuses on how variations in different spacers within polytopic L2-based HPV antigens affect their immunogenicity. The main findings of the paper include: 1. **Effect of Spacers on Immunogenicity**: Through experiments, the authors found that six different spacers (composed of glycine and proline) inserted upstream of specific L2 epitopes could affect the antigen's immunogenicity in different ways. Particularly, the antigens M8merV6 and C12merV6 demonstrated a stronger ability to induce neutralizing antibodies. 2. **Selection of Optimal Spacers**: The study results indicate that there is no universally optimal spacer, as its effectiveness seems to be influenced by the length and composition of the polytopic epitopes. 3. **Correlation of Antibody Levels**: The paper also explores the correlation between total anti-L2 antibody levels and neutralizing antibody levels, finding a significant correlation for certain HPV types. 4. **Monoclonal Antibody Affinity Analysis**: Using surface plasmon resonance (SPR) technology, the researchers assessed the affinity between different antigen variants and specific monoclonal antibodies. The results show that the affinity of these antibodies for different antigen variants is significantly correlated with their ability to induce neutralizing antibodies. In summary, this study aims to optimize the design of L2-based HPV antigens by altering spacers to enhance their ability to induce neutralizing antibodies, thereby providing theoretical basis and technical support for the development of more effective HPV vaccines.